Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study
- PMID: 28529192
- DOI: 10.1016/j.ijsu.2017.05.037
Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study
Abstract
Objectives: Radical pelvic exenteration can be undertaken for locally invasive or recurrent disease in both colorectal and gynaecological malignancies. In the UK this procedure is usually undertaken by the respective surgical specialties who have undergone divergent surgical training. This study describes and compares outcomes between colorectal and gynae-oncological teams following pelvic exenteration for primary and recurrent gynaecological and colorectal cancers in a single-centre multi-disciplinary team.
Method: A retrospective review of consecutive pelvic exenteration patients undertaken over a nine-year period in a tertiary referral centre. Analyses comparing short- and long-term morbidity and mortality outcomes were undertaken by chi-square test for categorical variables and Mann-Whitney U for continuous variables. Cumulative survival rates were calculated according to the Kaplan-Meier method and factors associated with recurrence and survival determined using a Cox regression model.
Results: Thirty-four exenterations were undertaken; fourteen colorectal and twenty gynae-oncological. Morbidity was seen in 50% of colorectal and 75% of gynae-oncological patients. Recurrence was seen earlier and with greater frequency in the gynaeoncology group (44.4% and median time 11 months) than the colorectal group (21.4%, median time 41 months; p > 0.05). Survival in the gynae-oncology group was also lower than the colorectal group at 1-year (69.6% vs. 92.9%) and 5-years (58.0% vs. 92.9%; p = 0.115). The majority of gynae-oncological mortality occurred within 3-years of surgery, whilst the majority of mortality in the colorectal group was after 5-years.
Conclusion: Long-term patient outcome measures, including disease recurrence and 5-year survival, for colorectal exenteration appear better than for gynaeoncology patients, however, no statistical significant difference exists between short-term outcome measures between specialties. This is likely to be caused by different baseline pathologies and disease pattern influencing longer term prognosis but may also be a function of differing surgical thresholds and patient selection bias between specialties. Peri-operative and short-term morbidity appear equivalent despite divergent surgical backgrounds and training.
Keywords: Colorectal; Gynae-oncological; Outcomes; Pelvic exenteration.
Copyright © 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Pelvic exenteration: long-term oncological results in a series of 106 patients.Acta Chir Belg. 2011 Sep-Oct;111(5):282-7. Acta Chir Belg. 2011. PMID: 22191128
-
Pelvic exenteration for primary and recurrent gynaecological malignancies.Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):243-8. doi: 10.1016/j.ejogrb.2006.07.025. Epub 2006 Sep 6. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 16950559
-
Open versus robotic-assisted techniques for multivisceral pelvic resections of locally advanced or recurrent colorectal and anal cancers: short-term outcomes from a single centre.Tech Coloproctol. 2024 Nov 19;28(1):161. doi: 10.1007/s10151-024-03044-9. Tech Coloproctol. 2024. PMID: 39560793 Free PMC article.
-
Minimally invasive pelvic exenteration for gynaecological malignancy: A single-centre case series and review of the literature.Eur J Obstet Gynecol Reprod Biol. 2022 Jul;274:56-61. doi: 10.1016/j.ejogrb.2022.05.003. Epub 2022 May 11. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35584578 Review.
-
Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.J Minim Invasive Gynecol. 2019 Nov-Dec;26(7):1316-1326. doi: 10.1016/j.jmig.2018.12.019. Epub 2019 Jan 4. J Minim Invasive Gynecol. 2019. PMID: 30611973 Review.
Cited by
-
A Systematic Review on Overall Survival and Disease-Free Survival Following Total Pelvic Exenteration.Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1137-1145. doi: 10.31557/APJCP.2022.23.4.1137. Asian Pac J Cancer Prev. 2022. PMID: 35485668 Free PMC article.
-
A systematic review and meta-analysis on mortality rate following total pelvic exenteration in cancer patients.BMC Cancer. 2024 May 15;24(1):593. doi: 10.1186/s12885-024-12377-5. BMC Cancer. 2024. PMID: 38750417 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical